참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Dexibuprofen | HCID 39912 | — |
| 용매 | Heptane | HCID 8900 | — |
| 생성물 | Ibuprofen, (+-)- | HCID 3672 | 361.2% |
반응 단계
Racemization and Distillation of R(-)-Enriched Ibuprofen. Heptane is removed as stream 18, FIG. 1, by distillation in an evaporator at atmospheric pressure from a mixture [stream 15, FIG. 1] containing S(+)-ibuprofen (0.1912 moles, 39.43 g), R(-)-ibuprofen (0.5136 moles, 105.95 g), and heptane (ca. 390 g). During the distillation, water [30 g, stream 17] is injected into the base of the evaporator to help strip out the last traces of heptane and to minimize formation of ibuprofen ethyl ester. The molten evaporation residue [stream 33], which consists essentially of ibuprofen with an S/R ratio of 27/73, is first racemized by being heated under nitrogen at 220° C. for four (4) hours and is then distilled at about 220° C., 10 mm HgA in an evaporator to provide a distillate [stream 19] of substantially pure racemized ibuprofen (0.6907 moles, 142.48 g, S/R ratio of 47:53) and an undistilled residue [stream 20, 2.91 g] for incineration as a waste stream. Racemized ibuprofen distillate [stream 19] is recycled to the first crop crystallization of crude S(+)-ibuprofen lysinate.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US05399707 |
|---|
| 출처 데이터셋 | uspto-grants-1995_03 |
|---|
| ORD ID | ord-198c5f9078fc443ea51a00d66785f190 |
|---|
| 출처 메모 | uspto-grants-1995_03 |
|---|